Literature DB >> 20597687

Care of rats with complete high-thoracic spinal cord injury.

John B G Ramsey1, Leanne M Ramer, Jessica A Inskip, Nima Alan, Matt S Ramer, Andrei V Krassioukov.   

Abstract

The complications of spinal cord injury (SCI) increase in number and severity with the level of injury. A recent survey of SCI researchers reveals that animal models of high SCI are essential. Despite this consensus, most laboratories continue to work with mid- or low-thoracic SCI. The available data on cervical SCI in animals characterize incomplete injuries; for example, nearly all studies published in 2009 examine discrete, tract-specific lesions that are not clinically-relevant. A primary barrier to developing animal models of severe, higher SCI is the challenge of animal care, a critical determinant of experimental outcome. Currently, many of these practices vary substantially between laboratories, and are passed down anecdotally within institutions. The care of animals with SCI is complex, and becomes much more challenging as the lesion level ascends. In our experience, the care of animals with high-thoracic (T3) SCI is much more demanding than the care of animals with low-thoracic SCI, even though both injuries result in paraplegia. We have developed an animal care regimen for rats with complete high-thoracic SCI. Our practices have been refined over the past 7 years, in collaboration with animal care centre staff and veterinarians. During this time, we have cared for more than 300 rats with T3 complete transection SCI, with experimental end-points of up to 3 months. Here we provide details of our animal care procedures, including acclimatization, housing, diet, antibiotic prophylaxis, surgical procedures, post-operative monitoring, and prevention of complications. In our laboratory, this comprehensive approach consistently produces good outcomes following T3 complete transection SCI: using body weight as an objective indicator of animal health, we have found that our rats typically return to pre-operative weights within 10 days of T3 complete SCI. It is our hope that the information provided here will improve care of experimental animals, and facilitate adoption of models that directly address the complications associated with higher level injuries.

Entities:  

Mesh:

Year:  2010        PMID: 20597687     DOI: 10.1089/neu.2010.1382

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  15 in total

1.  Rigid and remodelled: cerebrovascular structure and function after experimental high-thoracic spinal cord transection.

Authors:  A A Phillips; N Matin; B Frias; M M Z Zheng; M Jia; C West; A M Dorrance; I Laher; A V Krassioukov
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

2.  Tamoxifen Administration Immediately or 24 Hours after Spinal Cord Injury Improves Locomotor Recovery and Reduces Secondary Damage in Female Rats.

Authors:  Jennifer M Colón; Aranza I Torrado; Ámbar Cajigas; José M Santiago; Iris K Salgado; Yaría Arroyo; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2016-04-08       Impact factor: 5.269

3.  Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury.

Authors:  Matthieu Gautier; Lois Mahe; Jan Elaine Soriano; Andreas Rowald; Jordan W Squair; Arnaud Bichat; Newton Cho; Mark A Anderson; Nicholas D James; Jerome Gandar; Anthony V Incognito; Giuseppe Schiavone; Zoe K Sarafis; Achilleas Laskaratos; Kay Bartholdi; Robin Demesmaeker; Salif Komi; Charlotte Moerman; Bita Vaseghi; Berkeley Scott; Ryan Rosentreter; Claudia Kathe; Jimmy Ravier; Laura McCracken; Xiaoyang Kang; Nicolas Vachicouras; Florian Fallegger; Ileana Jelescu; YunLong Cheng; Qin Li; Rik Buschman; Nicolas Buse; Tim Denison; Sean Dukelow; Rebecca Charbonneau; Ian Rigby; Steven K Boyd; Philip J Millar; Eduardo Martin Moraud; Marco Capogrosso; Fabien B Wagner; Quentin Barraud; Erwan Bezard; Stéphanie P Lacour; Jocelyne Bloch; Grégoire Courtine; Aaron A Phillips
Journal:  Nature       Date:  2021-01-27       Impact factor: 49.962

Review 4.  Behavioral testing in animal models of spinal cord injury.

Authors:  K Fouad; C Ng; D M Basso
Journal:  Exp Neurol       Date:  2020-07-28       Impact factor: 5.330

5.  Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device.

Authors:  David Popok; Christopher West; Barbara Frias; Andrei V Krassioukov
Journal:  J Vis Exp       Date:  2016-07-29       Impact factor: 1.355

6.  Passive hind-limb cycling improves cardiac function and reduces cardiovascular disease risk in experimental spinal cord injury.

Authors:  Christopher R West; Mark A Crawford; Malihe-Sadat Poormasjedi-Meibod; Katharine D Currie; Andre Fallavollita; Violet Yuen; John H McNeill; Andrei V Krassioukov
Journal:  J Physiol       Date:  2014-02-17       Impact factor: 5.182

7.  Plasticity of TRPV1-Expressing Sensory Neurons Mediating Autonomic Dysreflexia Following Spinal Cord Injury.

Authors:  Leanne M Ramer; A Peter van Stolk; Jessica A Inskip; Matt S Ramer; Andrei V Krassioukov
Journal:  Front Physiol       Date:  2012-07-09       Impact factor: 4.566

8.  Effects of early exercise training on the severity of autonomic dysreflexia following incomplete spinal cord injury in rodents.

Authors:  Kathryn A Harman; Kathryn M DeVeau; Jordan W Squair; Christopher R West; Andrei V Krassioukov; David S K Magnuson
Journal:  Physiol Rep       Date:  2021-08

9.  Acute Cardiovascular Responses to Vagus Nerve Stimulation after Experimental Spinal Cord Injury.

Authors:  Rahul Sachdeva; Andrei V Krassioukov; Jesse E Bucksot; Seth A Hays
Journal:  J Neurotrauma       Date:  2020-04-01       Impact factor: 4.869

10.  Spinal cord transection-induced allodynia in rats--behavioral, physiopathological and pharmacological characterization.

Authors:  Saïd M'Dahoma; Sylvie Bourgoin; Valérie Kayser; Sandrine Barthélémy; Caroline Chevarin; Farah Chali; Didier Orsal; Michel Hamon
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.